Zika virus may help fight brain cancer

Image
IANS New York
Last Updated : Sep 06 2017 | 12:22 PM IST

While Zika virus is known to cause devastating damage to the brains of developing foetuses, it might one day help in the treatment against a deadly form of brain cancer, researchers claim.

The findings showed that Zika virus kills stem cells -- the kind of cells most resistant to standard treatments of glioblastoma, which is the most aggressive cancer that begins within the brain.

According to researchers, the lethal power of the Zika virus -- known for infecting and killing cells in the brains of foetuses, causing babies to be born with tiny, misshapen heads -- could be directed at malignant cells in the brain.

While the standard treatment kills the bulk of the tumour cells, it often leaves the stem cells intact to regenerate the tumour. Zika virus attacks the stem cells but bypasses the greater part of the tumour.

"We showed that Zika virus can kill the kind of glioblastoma cells that tend to be resistant to current treatments and lead to death," said Michael S. Diamond, Professor at Washington University School of Medicine in St. Louis.

The study, published in The Journal of Experimental Medicine, also suggest that Zika infection and chemotherapy-radiation treatment have complementary effects.

"We see Zika one day being used in combination with current therapies to eradicate the whole tumour," added Milan G. Chheda, Assistant Professor at the varsity.

For the study, the team injected Zika virus or saltwater (a placebo) directly into the brain tumours of two groups of mice.

Tumours were found to be significantly smaller in the Zika-treated mice two weeks after injection, and those mice survived significantly longer than the ones given saltwater.

If Zika were used in people, it would have to be injected into the brain, most likely during surgery to remove the primary tumour.

If introduced through another part of the body, the person's immune system would sweep it away before it could reach the brain, the researchers explained.

--IANS

rt/him/vm

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 06 2017 | 12:08 PM IST

Next Story